首页> 外文期刊>Pharmaceutical Chemistry Journal >DEVELOPMENT AND VALIDATION OF A PROCEDURE FOR ACYZOLE DETERMINATION IN WHOLE HUMAN BLOOD
【24h】

DEVELOPMENT AND VALIDATION OF A PROCEDURE FOR ACYZOLE DETERMINATION IN WHOLE HUMAN BLOOD

机译:人体血液中总儿茶酚含量测定方法的开发与验证

获取原文
获取原文并翻译 | 示例
           

摘要

7 An HPLC procedure using a HILIC column and UV detection was developed for determination of the carbon monoxide antidote acyzole in human blood after precipitation of proteins with MeCN. The chromatography was performed in isocratic mode over a Nucleodur HILIC column with MeCN:H_2O (95:5) mobile phase and detection at 225 nm. The lower limit of quantitation was 116.2 ng/mL; the upper limit, 11,111 ng/mL. Validation of the procedure confirmed that its selectivity, carry-over, linearity, limit of quantitation, precision and accuracy, recovery, and stability satisfied the established guidelines.
机译:7开发了一种使用HILIC色谱柱和UV检测的HPLC程序,用于在用MeCN沉淀蛋白质后测定人血中的一氧化碳解毒剂苯并咪唑。在具有MeCN:H_2O(95:5)流动相的Nucleodur HILIC色谱柱上以等度模式进行色谱分离,并在225 nm处检测。定量下限为116.2 ng / mL。上限为11,111 ng / mL。该方法的验证确认了其选择性,残留,线性,定量限,精密度和准确性,回收率和稳定性均满足既定准则。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号